scholarly journals Risk factors for human immunodeficiency virus among blood donors in Cameroon: evidence for the design of an Africa-specific donor history questionnaire

Transfusion ◽  
2017 ◽  
Vol 57 (8) ◽  
pp. 1912-1921 ◽  
Author(s):  
Claude T. Tagny ◽  
Georges Nguefack-Tsague ◽  
Diderot Fopa ◽  
Celestin Ashu ◽  
Estel Tante ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Blood Donors ◽  
Immunodeficiency Virus

scholarly journals Prevalence and risk factors of Human Immunodeficiency virus, Hepatitis B virus, Hepatitis C virus and Syphilis infections among nonprofessional blood donors in Chittagong, Bangladesh

2016 ◽  
Vol 1 (3) ◽  
pp. 518-525 ◽  
Author(s):  
Md Zobaidul Alam ◽  
Md Amayan Hossain ◽  
Mahmud A Chowdhury
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Blood Donors ◽  
Virus Hepatitis ◽  
Syphilis Infection ◽  
B Virus ◽  
Immunodeficiency Virus

Human Immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV) and Syphilis infection are the major public health problem, alarming the most developing countries like Bangladesh. These studies determined the prevalence rate and risk factors of HIV, Hepatitis B, Hepatitis C and Syphilis among nonprofessional blood donors in multiple blood transfusion center of Chittagong. Information was collected by questionnaire to find out the relationship of HIV, HBV, HCV and Syphilis infection with age, sex, socioeconomic status, residence and religious believes. The sero-prevalence of HIV, HBsAg (HBV), anti-HCV (HCV), VDRL (Syphilis) among the non-professional blood donors were 00.00%, 4.88%, 0.92%, and 0.70% respectively. So, the highest prevalence rate was HBsAg and the lowest was HIV. We didn’t find more than one positive case in the same blood sample. The prevalence of HBsAg among the study population, students (120/6) were 5.00%, service holders (73/3) were 4.11%, businessmen (40/4) were 10%, housewives (14/0) were 00.00%, others (farmers, immigrant workers) (40/1) were 2.50%. The highest prevalence of HBsAg was due to illiteracy and unsafe sexual behaviors.Asian J. Med. Biol. Res. December 2015, 1(3): 518-525

scholarly journals Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil

Transfusion ◽  
2013 ◽  
Vol 53 (11) ◽  
pp. 2734-2743 ◽  
Author(s):  
Paula Fraiman Blatyta ◽  
Brian Custer ◽  
Thelma Terezinha Gonçalez ◽  
Rebecca Birch ◽  
Maria Esther Lopes ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Blood Donors ◽  
Human Immunodeficiency Virus Risk ◽  
Immunodeficiency Virus ◽  
Computer Based

Prevalence, incidence, and risk factors of human immunodeficiency virus infection in blood donors in the Southeastern United States

Transfusion ◽  
2016 ◽  
Vol 57 (2) ◽  
pp. 404-411 ◽  
Author(s):  
Lauren A. Crowder ◽  
Whitney R. Steele ◽  
Edward P. Notari ◽  
Courtney K. Hopkins ◽  
Jose L.O. Lima ◽  
...  
Keyword(s):  
United States ◽  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Blood Donors ◽  
Southeastern United States ◽  
Immunodeficiency Virus

Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria

Transfusion ◽  
2007 ◽  
Vol 47 (4) ◽  
pp. 608-614 ◽  
Author(s):  
Cesar de Almeida Neto ◽  
William McFarland ◽  
Edward L. Murphy ◽  
Sanny Chen ◽  
Fatima Aparecida Hangai Nogueira ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Blood Donors ◽  
Sao Paulo ◽  
São Paulo ◽  
Immunodeficiency Virus ◽  
Donor Deferral

scholarly journals An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors

Transfusion ◽  
2013 ◽  
Vol 53 (10pt2) ◽  
pp. 2431-2440 ◽  
Author(s):  
Jingxing Wang ◽  
Jing Liu ◽  
Yi Huang ◽  
Tonghan Yang ◽  
Fuzhu Yao ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Blood Donors ◽  
Immunodeficiency Virus

Prevalence of and Risk Factors for Low Free Testosterone Levels in Japanese Men with Well-controlled Human Immunodeficiency Virus Infection

2020 ◽  
Vol 18 (5) ◽  
pp. 381-386
Author(s):  
Yusuke Yoshino ◽  
Ichiro Koga ◽  
Yoshitaka Wakabayashi ◽  
Takatoshi Kitazawa ◽  
Yasuo Ota
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Standard Deviation ◽  
Hiv Infection ◽  
Free Testosterone ◽  
Serum Levels ◽  
University Hospital ◽  
Rapid Decline ◽  
Total Testosterone ◽  
Immunodeficiency Virus

Background: The change in the prevalence of hypogonadism with age in men with human immunodeficiency virus (HIV) infection is subject to debate. Objective: To address this issue, we diagnosed hypogonadism based on serum levels of free testosterone (fTST) rather than total testosterone which is thought to be an inaccurate indicator. We also determined the relationship between age and fTST levels and identified risk factors for hypogonadism in men with HIV infection. Method: We retrospectively reviewed fTST levels and associated clinical factors in 71 wellcontrolled HIV-infected men who were treated at Teikyo University Hospital between April 2015 and March 2016 and who had data available on serum fTST levels, measured >6 months after starting antiretroviral therapy. fTST was measured using radioimmunoassay on blood samples collected in the morning. Risk factors for hypogonadism were identified using Welch’s t-test and multiple regression analysis. Results: The men had a mean (± standard deviation) age of 47.4 ± 13.6 years, and mean (± standard deviation) serum fTST level of 13.0 ± 6.1 pg/mL. Fifteen (21.1%) men had hypogonadism based on a fTST <8.5 pg/mL. Serum fTST levels significantly decreased with age (−0.216 pg/mL/year). Older age and low hemoglobin levels were identified as risk factors for hypogonadism. Conclusion: The men in the study experienced a more rapid decline in fTST levels with age than men in the general population (−0.161 pg/mL/year). Serum fTST levels in men with HIV infection should be monitored, especially in older men and those with low hemoglobin levels.

scholarly journals Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017

2021 ◽  
Vol 18 (9) ◽  
pp. 4623
Author(s):  
Sherali Massavirov ◽  
Kristina Akopyan ◽  
Fazlkhan Abdugapparov ◽  
Ana Ciobanu ◽  
Arax Hovhanessyan ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Treatment Outcomes ◽  
Sputum Smear ◽  
People Living With Hiv ◽  
Tb Treatment ◽  
Cell Counts ◽  
Cd4 Cell Counts ◽  
Immunodeficiency Virus ◽  
Positive Sputum Smear

Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection poses a growing clinical challenge. People living with HIV have a higher chance of developing TB, and once the disease has progressed, are at greater risk of having unfavorable TB treatment outcomes. Data on TB treatment outcomes among the HIV-associated TB population in Uzbekistan are limited. Thus, we conducted a cohort study among 808 adult patients with HIV-associated TB registered at the Tashkent TB referral hospital from 2013–2017 to document baseline characteristics and evaluate risk factors for unfavorable TB treatment outcomes. The data were collected from medical records and ambulatory cards. About 79.8% of the study population had favorable treatment outcomes. Antiretroviral therapy (ART) coverage at the admission was 26.9%. Information on CD4-cell counts and viral loads were largely missing. Having extrapulmonary TB (aOR 2.21, 95% CI: 1.38–3.53, p = 0.001), positive sputum smear laboratory results on admission (aOR 1.62, 95% CI: 1.07–2.40), diabetes (aOR 5.16, 95% CI: 1.77–14.98), and hepatitis C (aOR 1.68, 95% CI: 1.14–2.46) were independent risk factors for developing unfavorable TB treatment outcomes. The study findings provide evidence for targeted clinical management in co-infected patients with risk factors. Strengthening the integration of TB/HIV services may improve availability of key data to improve co-infection management.

Sign in / Sign up

Export Citation Format

Share Document